Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to cardiovascular
disease (CVD). The aim of this study is to assess whether and to what extent the excess risk …

According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are obesity‐related
conditions with high cardiovascular mortality. Whether NAFLD is independently associated …

Introduction We characterized the association of 3 metabolic conditions–obesity, metabolic
syndrome, and nonalcoholic fatty liver disease (NAFLD)–with increased inflammation and …

Background and aim Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of
the metabolic syndrome, was associated with subclinical atherosclerosis in many cross …

Non-alcoholic fatty liver disease (NAFLD) is an emerging chronic liver disease that may lead
to liver cirrhosis and hepatocellular carcinoma. We aimed to determine the association …

Assessment of major adverse cardiovascular events (MACE) after liver transplantation (LT)
has been limited by the lack of a multicenter study with detailed clinical information. An …

Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, is characterized
by accumulation of fat (> 5% of the liver tissue), in the absence of alcohol abuse or other …

Nonalcoholic fatty liver disease (NAFLD) is one of the main chronic noncommunicable
diseases in Westernized societies; its worldwide prevalence has doubled during the last 20 …